Stocktoria
Unicycive Therapeutics, Inc. UNCY
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-06-17
Chart by TradingView
2/9
Piotroski F — financial health
-6.84
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Dividends
Safetyno dividend
| FY | 2024 | 2023 |
|---|---|---|
| Total dividends paid | $1.1M | $900,000 |
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | — | — | $675,000 | $951,000 | — |
| Operating income | -$29.5M | -$32.1M | -$20.8M | -$18.1M | -$9.0M |
| Net income | -$26.6M | -$36.7M | -$30.5M | -$18.1M | -$10.0M |
| Operating cash flow | -$31.3M | -$28.6M | -$18.3M | -$15.7M | -$5.8M |
| Free cash flow | -$31.3M | -$28.6M | -$18.3M | -$15.7M | -$5.8M |
| Total assets | $49.1M | $31.7M | $14.2M | $2.8M | $18.7M |
| Total liabilities | $18.9M | $24.2M | $18.0M | $3.3M | $2.3M |
| Shareholders' equity | $30.2M | $7.4M | -$3.8M | -$466,000 | $16.5M |
| Ratios | |||||
| Operating margin | — | — | -3077.6% | -1898.2% | — |
| Net margin | — | — | -4525.0% | -1898.8% | — |
| FCF margin | — | — | -2710.4% | -1646.0% | — |
| Return on assets | -54.0% | -116.0% | -215.2% | -640.8% | -53.4% |
| Return on equity | -87.9% | -494.3% | 801.9% | 3875.1% | -60.8% |
| Current ratio | 2.59 | 1.28 | 0.76 | 0.81 | 8.75 |
| Revenue growth | — | — | -29.0% | — | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 24,400 | $160,552 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -6.84 (distress)
- Working capital / assets 0.611
- Retained earnings / assets -2.602
- EBIT / assets -0.601
- Equity / liabilities 1.595
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001766140 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.